A welcome debate on statistical analysisMULLINS, C. Daniel.Clinical therapeutics. 2001, Vol 23, Num 10, issn 0149-2918, p. 1746Article

Criteria to request pharmacoeconomic data and data sources for hospital formulary decisionsKULSOMBOON, Vithaya; PALUMBO, Francis B; MULLINS, C. Daniel et al.Drug information journal. 2001, Vol 35, Num 1, pp 231-240, issn 0092-8615Article

Major components of the direct medical costs of α₁-Antitrypsin deficiencyMULLINS, C. Daniel; JUNLING WANG; STOLLER, James K et al.Chest. 2003, Vol 124, Num 3, pp 826-831, issn 0012-3692, 6 p.Article

Use of a bayesian network to predict the nighttime intraocular pressure peak from daytime measurements. CommentaryMULLINS, C. Daniel; NORDMANN, Jean-Philippe; BERDEAUX, Gilles et al.Clinical therapeutics. 2007, Vol 29, Num 8, issn 0149-2918, 1750-1760Article

Factors associated with hospitalization costs for patients with community-acquired pneumoniaMERCHANT, Sanjay; MULLINS, C. Daniel; SHIH, Ya-Chen Tina et al.Clinical therapeutics. 2003, Vol 25, Num 2, pp 593-610, issn 0149-2918, 18 p.Article

Statistical comparison of consumer drug expenditures and discretionary purchases to assess drug affordability. CommentaryMULLINS, C. Daniel; LEE, James A; MCKERCHER, Patrick L et al.Clinical therapeutics. 2002, Vol 24, Num 6, issn 0149-2918, 1002,1003-1016 [15 p.]Article

Pharmacists' Assessment of Facets of Health Literacy in Pharmacy Practice SettingsBRADLEY-BAKER, Lynette R; MULLINS, C. Daniel; BAQUET, Claudia R et al.The Journal of pharmacy technology. 2011, Vol 27, Num 2, pp 55-62, issn 8755-1225, 8 p.Article

Healthcare Rationing by Proxy: Cost-Effectiveness Analysis and the Misuse of the $50 000 Threshold in the USBRIDGES, John F. P; ONUKWUGHA, Eberechukwu; MULLINS, C. Daniel et al.PharmacoEconomics (Auckland). 2010, Vol 28, Num 3, pp 175-184, issn 1170-7690, 10 p.Article

Cost-of-illness studies : A review of current methodsAKOBUNDU, Ebere; JING JU; BLATT, Lisa et al.PharmacoEconomics (Auckland). 2006, Vol 24, Num 9, pp 869-890, issn 1170-7690, 22 p.Article

Assessment of compliance with antipsychotic treatment and resource utilization in a medicaid population. CommentaryMULLINS, C. Daniel; EADDY, Michael; GROGG, Amy et al.Clinical therapeutics. 2005, Vol 27, Num 2, pp 256-257, issn 0149-2918, 12 p.Article

Racial Disparities in Urologist Visits Among Elderly Men With Prostate Cancer: A Cohort Analysis of Patient-Related and County of Residence-Related FactorsONUKWUGHA, Eberechukwu; OSTEEN, Phillip; JAYASEKERA, Jinani et al.Cancer. 2014, Vol 120, Num 21, pp 3385-3392, issn 0008-543X, 8 p.Article

Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult OncologyBASCH, Ethan; ABERNETHY, Amy P; FRANK, Elizabeth S et al.Journal of clinical oncology. 2012, Vol 30, Num 34, pp 4249-4255, issn 0732-183X, 7 p.Article

Policy Implications of Drug ImportationPALUMBO, Francis B; MULLINS, C. Daniel; SLAGLE, Ashley F et al.Clinical therapeutics. 2007, Vol 29, Num 12, pp 2758-2767, issn 0149-2918, 10 p.Article

Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population. CommentaryMULLINS, C. Daniel; FERNANDES, Ancilla W; MADHAVAN, S. Suresh et al.Clinical therapeutics. 2005, Vol 27, Num 5, pp 628-629, issn 0149-2918, 18 p.Article

Comparisons of hypertension-related costs from multinational clinical studiesMULLINS, C. Daniel; SIKIRICA, Mirko; SENEVIRATNE, Viran et al.PharmacoEconomics (Auckland). 2004, Vol 22, Num 15, pp 1001-1014, issn 1170-7690, 14 p.Article

Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. CommentaryFAIRMAN, Kathleen A; MOTHERAL, Brenda R; HENDERSON, Rochelle R et al.Clinical therapeutics. 2003, Vol 25, Num 12, pp 3144-3146, issn 0149-2918, 18 p.Article

Cervical cancer outcomes analysis : Impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervixBROOKS, Sandra E; CHEN, T. Timothy; GHOSH, Abhijit et al.Gynecologic oncology (Print). 2000, Vol 79, Num 1, pp 107-115, issn 0090-8258Conference Paper

Comparative and Cost Effectiveness of Treatment Modalities for Hepatocellular Carcinoma in SEER-MedicareSHAYA, Fadia T; BREUNIG, Ian M; SEAL, Brian et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 1, pp 63-74, issn 1170-7690, 12 p.Article

Comparative Effectiveness of Different Chemotherapeutic Regimens on Survival of People Aged 66 and Older with Stage III Colon Cancer: A Real World Analysis Using Surveillance, Epidemiology, and End Results―Medicare DataHSIAO, Fei-Yuan; MULLINS, C. Daniel; ONUKWUGHA, Ebere et al.Journal of the American Geriatrics Society. 2011, Vol 59, Num 9, pp 1717-1723, issn 0002-8614, 7 p.Article

Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophreniaMULLINS, C. Daniel; OBEIDAT, Nour A; CUFFEL, Brian J et al.Schizophrenia research. 2008, Vol 98, Num 1-3, pp 8-15, issn 0920-9964, 8 p.Article

Comparison of first refill rates among users of sertraline, paroxetine, and citalopramMULLINS, C. Daniel; SHAYA, Fadia T; MENG, Fanlun et al.Clinical therapeutics. 2006, Vol 28, Num 2, pp 297-305, issn 0149-2918, 9 p.Article

Selective cyclooxygenase-2 inhibition and cardiovascular effects : An observational study of a medicaid populationSHAYA, Fadia T; BLUME, Steven W; BLANCHETTE, Christopher M et al.Archives of internal medicine (1960). 2005, Vol 165, Num 2, pp 181-186, issn 0003-9926, 6 p.Article

Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in MedicaidMULLINS, C. Daniel; COOKE, Jesse L; JUNLING WANG et al.Journal of the National Medical Association. 2004, Vol 96, Num 6, pp 809-816, issn 0027-9684, 8 p.Article

Longitudinal versus cross-sectional methodology for estimating the economic burden of breast cancer: A pilot studyMULLINS, C. Daniel; JUNLING WANG; COOKE, Jesse L et al.PharmacoEconomics (Auckland). 2004, Vol 22, Num 5, pp 285-291, issn 1170-7690, 7 p.Article

Cost-Effectiveness of Second-Line Chemotherapy/ Biologics among Elderly Metastatic Colon Cancer PatientsZHIYUAN ZHENG; ONUKWUGHA, Eberechukwu; HANNA, Nader et al.Advances in therapy. 2014, Vol 31, Num 7, pp 724-734, issn 0741-238X, 11 p.Article